Targeting autophagy reverses de novo resistance in homologous recombination repair proficient breast cancers to PARP inhibition. Pai Bellare G, Saha B, Patro BS. Br J Cancer 2021;124:1260-1274.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pai Bellare G, Saha B, Patro BS. Targeting autophagy reverses de novo resistance in homologous recombination repair proficient breast cancers to PARP inhibition. Br J Cancer 2021;124:1260-1274.
PMID: 33473172